TrademarkOpen
Search / United States / 97653118

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

MORPHIC

Registered
Used for: Pharmaceuticals and pharmaceutical preparations for use in the treatment of autoimmune, cardiovascular and metabolic…
Show more

Pharmaceuticals and pharmaceutical preparations for use in the treatment of autoimmune, cardiovascular and metabolic diseases, as well as fibrosis and cancer

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 1 Nov 2022
    Application filed
    New Application Entered
  2. 11 Aug 2023
    Assigned to an examining attorney
    Assigned To Examiner
  3. 18 Aug 2023
    Approved for publication
    Approved For Pub - Principal Register
  4. 26 Sep 2023
    Published for opposition
    Published For Opposition
  5. 21 Nov 2023
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  6. 20 May 2024
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  7. 30 Jul 2024
    Statement of use filed
    Teas Statement Of Use Received
  8. 9 Oct 2024
    Response to office action filed
    Teas Response To Office Action Received
  9. 23 Dec 2024
    Statement of use accepted
    Allowed Principal Register - Sou Accepted
  10. 14 Jan 2025
    Registered on the Principal Register
    Registered-Principal Register
All 30 events
2025-01-14Registered-Principal Register
2025-01-14Notice Of Registration Confirmation Emailed
2024-12-23Allowed Principal Register - Sou Accepted
2024-12-23Notice Of Acceptance Of Statement Of Use E-Mailed
2024-11-27Statement Of Use Processing Complete
2024-10-09Teas Response To Office Action Received
2024-10-09Response To Itu Office Action Entered
2024-09-30Case Assigned To Intent To Use Paralegal
2024-09-30Applicant/Correspondence Changes (Non-Responsive) Entered
2024-09-30Itu Office Action Issued For Statement Of Use
2024-08-28Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2024-08-28Attorney/Dom.rep.revoked And/Or Appointed
2024-08-28Teas Change Of Correspondence Received
2024-08-28Teas Withdrawal Of Attorney Received-Firm Retains
2024-07-30Teas Statement Of Use Received
2024-07-30Use Amendment Filed
2024-06-11Teas Post Publication Amendment Received
2024-05-21Notice Of Approval Of Extension Request E-Mailed
2024-05-20Sou Teas Extension Received
2024-05-20Sou Extension 1 Filed
2024-05-20Sou Extension 1 Granted
2023-11-21Noa Mailed - Sou Required From Applicant
2023-09-26Published For Opposition
2023-09-26Official Gazette Publication Confirmation E-Mailed
2023-09-06Notification Of Notice Of Publication E-Mailed
2023-08-18Approved For Pub - Principal Register
2023-08-11Assigned To Examiner
2022-11-16Notice Of Design Search Code E-Mailed
2022-11-15New Application Office Supplied Data Entered
2022-11-01New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceuticals and pharmaceutical preparations for use in the treatment of autoimmune, cardiovascular and metabolic diseases, as well as fibrosis and cancer

First use anywhere 2 Jul 2024 · First use in commerce 2 Jul 2024

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 14 Jan 2025; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.